The effect of TGF-β1 polymorphisms on pulmonary disease progression in patients with cystic fibrosis

被引:8
|
作者
Trojan, T. [1 ,2 ]
Alcazar, Miguel A. Alejandre [3 ,4 ,5 ,6 ,7 ]
Fink, G. [3 ,4 ,5 ]
Thomassen, J. C. [1 ,2 ]
Maessenhausen, M., V [1 ,2 ]
Rietschel, E. [1 ,2 ]
Schneider, P. M. [5 ,8 ]
Van Koningsbruggen-Rietschel, S. [1 ,2 ]
机构
[1] Childrens Hosp, Fac Med, CF Ctr Cologne, Kerpener Str 62, D-50937 Cologne, Germany
[2] Univ Cologne, Kerpener Str 62, D-50937 Cologne, Germany
[3] Univ Cologne, Fac Med, Ctr Mol Med Cologne CMMC, Dept Pediat & Adolescent Med,Translat Expt Pediat, Cologne, Germany
[4] Univ Cologne, Fac Med, Cologne Excellence Cluster Stress Responses Agein, Cologne, Germany
[5] Univ Cologne, Univ Hosp Cologne, Cologne, Germany
[6] Univ Giessen & Marburg Lung Ctr UGMLC, Inst Lung Hlth ILH, Giessen, Germany
[7] Germany Ctr Lung Res DZL, Giessen, Germany
[8] Univ Cologne, Fac Med, Inst Legal Med, Cologne, Germany
关键词
Transforming-growth-factor Beta 1 (TGF-beta(1)); Cystic fibrosis; Polymorphisms; Inflammation; Forced expiratory volume in one second (FEV1); Pseudomonas aeruginosa; TRANSFORMING GROWTH-FACTOR-BETA-1; ASSOCIATION; CHILDREN; DECLINE;
D O I
10.1186/s12890-022-01977-1
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background: Transforming Growth Factor-beta(1) (TGF-beta(1)) is a genetic modifier in patients with cystic fibrosis (CF). Several single nucleotide polymorphisms (SNPs) of TGF-beta(1) are associated with neutrophilic inflammation, lung fibrosis and loss of pulmonary function. Aim: The aim of this study was to assess the relationship between genetic TGF-beta(1) polymorphisms and pulmonary disease progression in CF patients. Furthermore, the effect of TGF-beta(1) polymorphisms on inflammatory cytokines in sputum was investigated. Methods: 56 CF-patients and 62 controls were genotyped for three relevant SNPs in their TGF-beta(1) sequence using the SNaPshot (R) technique. Individual "slopes" in forced expiratory volume in 1 s (FEV1) for all patients were calculated by using documented lung function values of the previous five years. The status of Pseudomonas aeruginosa (Pa) infection was determined. Sputum concentrations of the protease elastase, the serine protease inhibitor elafin and the cytokines IL-1 beta, IL-8, IL-6,TNF-alpha were measured after a standardized sputum induction and processing. Results: The homozygous TT genotype at codon 10 was associated with a lower rate of chronic Pa infection (p < 0.05). The heterozygous GC genotype at codon 25 was associated with lower lung function decline (p< 0.05). Patients with homozygous TT genotype at the promotor SNP showed higher levels ofTNF-alpha (p < 0,05). Higher levels of TGF-beta(1) in plasma were associated with a more rapid FEV1 decline over five years (p< 0.05). Conclusions: Our results suggest that polymorphisms in the TGF-beta(1) gene have an effect on lung function decline, Pa infection as well as levels of inflammatory cytokines. Genotyping these polymorphisms could potentially be used to identify CF patients with higher risk of disease progression. TGF-beta(1) inhibition could potentially be developed as a new therapeutic option to modulate CF lung disease.
引用
收藏
页数:10
相关论文
共 50 条
  • [21] Glucocorticoid receptor gene polymorphisms associated with progression of lung disease in young patients with cystic fibrosis
    Corvol, Harriet
    Nathan, Nadia
    Charlier, Celine
    Chadelat, Katarina
    Le Rouzic, Philippe
    Tabary, Olivier
    Fauroux, Brigitte
    Henrion-Caude, Alexandra
    Feingold, Josue
    Boelle, Pierre-Yves
    Clement, Annick
    RESPIRATORY RESEARCH, 2007, 8 (1):
  • [22] Identifying treatments that halt progression of pulmonary disease in cystic fibrosis
    Davis, PB
    Byard, PJ
    Konstan, MW
    PEDIATRIC RESEARCH, 1997, 41 (02) : 161 - 165
  • [23] Identifying Treatments That Halt Progression of Pulmonary Disease in Cystic Fibrosis
    Pamela B Davis
    Pamela J Byard
    Michael W Konstan
    Pediatric Research, 1997, 41 : 161 - 165
  • [24] Long term effects of aerosolised rhDNase on pulmonary disease progression in patients with cystic fibrosis
    Milla, CE
    THORAX, 1998, 53 (12) : 1014 - 1017
  • [25] Association of TGF-β1 polymorphisms with chronic renal disease
    Coll, E
    Cormand, B
    Campos, B
    González-Núñez, D
    Iñigo, P
    Botey, A
    Poch, E
    JOURNAL OF NEPHROLOGY, 2004, 17 (06) : 794 - 799
  • [26] TGF-β1 gene polymorphisms and vascular disease in chronic hemodialysis patients.
    Rao, M
    Goo, DQ
    Tighiouart, H
    Jaber, BL
    Freeman, R
    Pereira, BJG
    Balakrishnan, VS
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 : 56A - 56A
  • [27] PULMONARY DISEASE IN PATIENTS WITH PANCREATIC CYSTIC FIBROSIS
    HANSEN, JJ
    GREENBERG, D
    ROSENBERG, HS
    HARRISON, GM
    SINGER, DB
    DISEASES OF THE CHEST, 1969, 56 (03): : 252 - +
  • [28] Bletilla striata polysaccharide attenuated the progression of pulmonary fibrosis by inhibiting TGF-β1/Smad signaling pathway
    Wang, Siqi
    Yu, Jiabao
    Liu, Yang
    Yu, Jinjin
    Ma, Yajing
    Zhou, Lili
    Liu, Xinyao
    Liu, Lingyi
    Li, Weifeng
    Niu, Xiaofeng
    JOURNAL OF ETHNOPHARMACOLOGY, 2024, 323
  • [29] TGF-β1 ACTIVATION IN CYSTIC FIBROSIS CELL CULTURE MODEL SYSTEMS
    Harris, W. T.
    Grenett, H. E.
    Macewan, M.
    Clancy, J. P.
    PEDIATRIC PULMONOLOGY, 2010, : 249 - 249
  • [30] Accumulation of AIF1 in Lung Fibroblasts Enhances Response to TGF-β and Advances Pulmonary Fibrosis Progression
    Liu, Lian
    EUROPEAN RESPIRATORY JOURNAL, 2024, 64